Next-Generation Sequencing Stays Ahead of the Market Curve

Next-Generation Sequencing Stays Ahead of the Market Curve

The impact of genetic sequencing on life sciences research, biotechnology and medicine is unprecedented. In 25 years, genomic knowledge has been built on a staggering scale: first enabled with the innovation and commercialization of Sanger sequencing, pieced together in coordinated efforts between various institutes, and then tremendously accelerated with the introduction of higher-throughput next-generation sequencing (NGS) technologies. Sequencing remains a dynamic space that has escaped marke...

  • by bcarlson@marketresearch.com
  • March 24 2015


Healthcare Reform Has Impact in Glucose Testing

Among the industries impacted by healthcare reform, we’ve predicted in our report on the ACA that IVD would fair better than pharma or non-testing medical devices. Testing is by its nature preventative, and the theory was that more office visits from newly insured patients should lead to more. According to a story in Fierce Healthcare, this has already happened in glucose testing. Glucose testing is up where patients are covered. The next question would be "Will this impact patient health direct...


Gene Therapies Target an Over $100 Billion Cancer Treatment Market

Gene Therapies Target an Over $100 Billion Cancer Treatment Market

Modern medicine’s more than century-long fight to treat cancer and eradicate tumors will likely benefit from a more diverse and effective arsenal in the coming years. Through a variety of routes and techniques, gene therapies are able to deliver genetic material to a specific cell population or tumor that will result in the destruction of the tumor. Gene therapies have already found clinical successes in the treatment of several non-cancer diseases, though the oncolytic or immune system-assisted...


Broad-Based Growth Evident in Latin American IVD Market

Broad-Based Growth Evident in Latin American IVD Market

Brazil figures heavily into IVD strategies for the Latin American continent with a population of over 200 million people and industry to support globally distributed supply operations. However, the country’s regional economic clout does not necessarily ensure its status as a leading target expansion market for IVD companies. According to Kalorama Information’s latest projections for the Latin American IVD market , the less competitive IVD markets of Chile, Colombia and Peru are expected to grow ...